Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre

First Page		Document Content
Date: 2014-06-13 01:07:42 Polycythemia vera Essential thrombocytosis Fibrosis Medicine Myeloproliferative disease Myelofibrosis		Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre Add to Reading List Source URL: www.promedior.com Download Document from Source Website File Size: 1,74 MB Share Document on Facebook